Immunological Effects of Interferon-alpha on Chronic Myelogenous Leukemia

References

• Sawyers, C.L. (1999) "Chronic tnyelogenous leukemia". New England Journal of Medicine 340, 1330–1340.
   PubMed Web of Science ®Google Scholar
• Kalidas, M.. Kantarjian, H. and Talpaz, M. (2001) "Chronic myelogenous leukemia", Journal of the American Medical Association 286, 895–898.
   PubMed Web of Science ®Google Scholar
• Lee, I.S. (2000) "Chronic myelogenous leukemia", British Journal of Hematology 111, 993–1009.
   PubMed Web of Science ®Google Scholar
• Kolb, J.H., Mittennuller, J,, Clemm, C., Ledderooe, G., Brehm, G., Heim. M. and Wilmans, W. (1990) "Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients", Blood 76, 2462–2465.
   PubMed Web of Science ®Google Scholar
• Cullis,1.0., Jiang, Y.Z., Schwarer, AR, Hughes, T.P., Barrett, A.J. and Goldman, J.M. (1992) -Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation", Blood 79, 1379–1381.
   Google Scholar
• Sala. L.M., Pincus, S.M„ Locker, J.D. and Glover, J. (1995) "Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukemia and their role in the in vitro disappearance of BCR-ABL positive targets", British Journal of Haematology 93, 375–385.
   Web of Science ®Google Scholar
• Jiang, YZ., Barrett, A.J., Goldman, J.M. and Mayroudis. D.A. (1997) "Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation", Annals of Hematology 14, 1–6.
   Web of Science ®Google Scholar
• Kantarjian, ELM., Smith, T.L. and O'Brien, S. (1995) "Prolonged survival following achievement of cytogenetic response with alpha-interferon therapy in chronic myelogenous leukemia", Annals of Internal Medicine 122, 254–261.
   PubMed Web of Science ®Google Scholar
• Silver, R.T., Woolf, S.H.. Hehlmann, R., Appelbaum. F.R., Anderson, J., Bennett, C., Goldman, J.M., Guilhot. F., Kantarjian, H.M., Lichtin, A.E., Talpaz, M. and Tura, S. (1999) "An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology". Blood 94, 1517–1536.
   PubMed Web of Science ®Google Scholar
• Guilhot, F. and Lacotte-Thierry, L. (1998) "Interferon-a: mechan-isms of action in chronic myelogenous leukemia in chronic phase", Hematology and Cell Therapy 40, 237–239.
   PubMedGoogle Scholar
• Jonasch, E. and Haluska, F.G. (2001) "Interferon in oncological practice: review of interferon biology, clinical applications and toxicities", Oncology 6, 34–55.
   Web of Science ®Google Scholar
• Guarini, A., Massimo, B., Montefusco, E„ Petti, M.C., Zepparoni, A., Vitale, A. and Foa, R. (2001) "Phenotypic and functional characterisation of the host immune compartment of chronic myeloid leukemia patients in complete hematological remission", British Journal of Hematology 113, 136–142.
   PubMed Web of Science ®Google Scholar
• Ravandi, F., Kantarjian, HJvL, Talpaz, M., O'brien, S., Fader!, S., Giles, F.J., Thomas, D., Cortes, J., Andreoff, M., F-strov, Z., Rios, M3. and Albitar, M. (2001) "Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance", Cancer 91, 1964–1972.
   Google Scholar
• Kasimir-Bauer, S., ()Ringer, H., Wuttke, M., Stellberg, W., Grosse-Wilde, H., Seeber, S., Scheulen, M.E., "Chronic myelo-genous leukemia: effect of interferon-alpha treatment on phagocytic activity and capacity of circulating neutrophils". Leukemia Research, 22, 115–117
   Google Scholar
• Pawelec, G., da Silva, P.. Max, H., Kalbacher, H., Schmidt, 1–1., Bruserud, 0., Zugel, U., Baier, W., Rehbein, A. and Pohla, H. (1995) "Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha", Leukemia and Lymphoma 18, 471–478.
   Web of Science ®Google Scholar
• Boyum, A. (1977) "Isolation of lymphocytes, granulocytes and macrophages", Scandinavian Journal of Immunology (Suppl. 5), 9–15.
   Web of Science ®Google Scholar
• Chang, L., Gusewitch, AG,, Chritton, D.B.W., Folz, IC., Lebeck, L.K. and Canntu-ella, S.L.N. (1993) -Rapid flow cytometric assay for the assessment of natural killer cell activity". Journal of Immunological Methods 166, 45–52.
   Google Scholar
• Jung, T., Schauer, U., Heusser, C., Neumann, C. and Rieger, C. (1993) "Detection of intracellular cytokines by flow cytometry", Journal of Immunological Methods 159, 197–207.
   PubMed Web of Science ®Google Scholar
• Aglietta, M., Piacibello, W., Stacchinni, A., Dezza, F., Sanavio, F., Malavasi, F., Infelise, V, Resegotti, L. and Gavosto, F. (1986) "Expression of HLA class II (DR, DQ) determinants by normal and chronic granulocytehnonocyte progenitors", Cancer Research 46, 1783–1787.
   PubMed Web of Science ®Google Scholar
• Pardoll, D.M. and Topalian, S.L. (1998) "The role of CD4+ cell responses in antitumor immunity", Current Opinion Inimunology 42, 588–594.
   Web of Science ®Google Scholar
• Castro, EA„ Paula-Santos, C.M. and Voltarelli, J.C. (1999) "Stimulation of HLA-DR antigen expression in acute and chronic leukemia". Cancer Research and Therapy Contro110, 93–99.
   Google Scholar
• Bishop, GA. and Hostager, B.S. (2001) "B lymphocyte activation by contact-mediated interactions with T lymphocytes", Current Opinion in Immunology 13. 278–285.
   PubMed Web of Science ®Google Scholar
• Deininger. M.W.N., Goldman, J.M. and Melo, J.V. (2000) "The molecular biology of chronic myeloid leukemia", Blood 96, 3343–3356.
   PubMed Web of Science ®Google Scholar
• Silla, L.M., Whiteside. T.L. and Ball, E.D. (1995) "The role of natural killer cells in the treatment of chronic myeloid leukemia", Journal of Hematotheraphy 4, 269–279.
   Google Scholar
• Abbas, A.K., Murphy, K.M. and Sher, A. (1996) "Functional diversity of helper T lymphocyte", Nature 383, 787–793.
   PubMed Web of Science ®Google Scholar
• Murray, J.S. (1998) "How the MHC selects Th 1-Th2 immunity", Immunology Today 19, 157–162.
   PubMedGoogle Scholar
• Fuchs, El., Bedi, A., Jones, R.I. and Hess, A.D. (1995) "Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis", Cancer Research 55, 238–249.
   Web of Science ®Google Scholar
• Langtade-Demoyen, P., Abastado, IF.. Even, J., Gouru, G., Lebton, V., Binet, J.L. and Kourilsky, P. (1995) "Cytotoxicity T cell response against 210 IcDA chimeric protein coded by the BCR-ABL fusion gene in chronic myeloid leukemia", Blood 86, 525–537.
   Web of Science ®Google Scholar
• Whiteside, T.L., Vujanovic, N.L. and Herberman, R.B. (1998) "Natural killer cells and tumor therapy", Current Topics in Microbiology and Immunology 230, 221–244.
   PubMed Web of Science ®Google Scholar
• Molldrem, J.J., Lee, P.P., Wang, C., Felio, K., Kantarjian, H.M., Champlin, R.E. and Davis, M.M. (2000) "Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia", Nature Medicine 6, 1018–1023.
   PubMed Web of Science ®Google Scholar
• Silver, R.T., Bean, P., Verma, R.S., Coleman, M., Soper. L. and Gutfriend, A. (1990) "Recombinant gamma-interferon has activity in chronic myelogenous leukemia". American Journal of Clinical Oncology 13, 49–54,
   PubMed Web of Science ®Google Scholar
• Reuben, J.M., Lee, B.N., Johnson, H., Fristsche, H., Kantarjian, H.M. and Talpaz, M. (2000) "Restoration of Thl cytokine synthesis by T cells of patients with chronic myelogenous leukemia in cytogenetic and hematologic remission with interferon-alpha", Clinical Cancer Research 6, 1671–1677.
   PubMed Web of Science ®Google Scholar
• Tsuda, H. and Yamasaki. H. (2000) "Type I and II T cell profiles in chronic myelogenous leukemia", Acta Hematologica 103, 96–101.
   PubMed Web of Science ®Google Scholar
• Fujii, S. (2000) "Role of interferon-alpha and clonally expanded T cells in the immunotherapy of chronic myelogenous leukemia-, Leukemia and Lymphoma 38, 21–38.
   Google Scholar
• Pawelec, G., Rehbein, A., Schlotz, E. and da Silva, P. (1996) "Cellular immune responses to autologous chronic myelogenous leukemia cells in vitro", Cancer Immunology and Immunotherapy 42, 193–199.
   PubMed Web of Science ®Google Scholar